DNA Methylation Changes during In Vitro Propagation of Human Mesenchymal Stem Cells: Implications for Their Genomic Stability?

Mesenchymal stem cells (MSCs) hold great promise for the treatment of numerous diseases. A major problem for MSC therapeutic use is represented by the very low amount of MSCs which can be isolated from different tissues; thus ex vivo expansion is indispensable. Long-term culture, however, is associated with extensive morphological and functional changes of MSCs. In addition, the concern that they may accumulate stochastic mutations which lead the risk of malignant transformation still remains. Overall, the genome of human MSCs (hMSCs) appears to be apparently stable throughout culture, though transient clonal aneuploidies have been detected. Particular attention should be given to the use of low-oxygen environment in order to increase the proliferative capacity of hMSCs, since data on the effect of hypoxic culture conditions on genomic stability are few and contradictory. Furthermore, specific and reproducible epigenetic changes were acquired by hMSCs during ex vivo expansion, which may be connected and trigger all the biological changes observed. In this review we address current issues on long-term culture of hMSCs with a 360-degree view, starting from the genomic profiles and back, looking for an epigenetic interpretation of their genetic stability.

[1]  T. Ye,et al.  Role of histone deacetylase inhibitors in the aging of human umbilical cord mesenchymal stem cells , 2013, Journal of cellular biochemistry.

[2]  Seok-Goo Cho,et al.  Clinical applications of mesenchymal stem cells , 2013, The Korean journal of internal medicine.

[3]  Manuel Serrano,et al.  The Hallmarks of Aging , 2013, Cell.

[4]  Kirsten R. McEwen,et al.  The impact of culture on epigenetic properties of pluripotent stem cells and pre-implantation embryos. , 2013, Biochemical Society transactions.

[5]  L. Bouzas,et al.  Stability of human mesenchymal stem cells during in vitro culture: considerations for cell therapy , 2013, Cell proliferation.

[6]  W. Wagner.  Implications of long-term culture for mesenchymal stem cells: genetic defects or epigenetic regulation? , 2012, Stem Cell Research & Therapy.

[7]  D. Yamaguchi,et al.  Constitutive Expression of Human Telomerase Enhances the Proliferation Potential of Human Mesenchymal Stem Cells , 2012, BioResearch open access.

[8]  M. Miloso,et al.  From cytogenomic to epigenomic profiles: monitoring the biologic behavior of in vitro cultured human bone marrow mesenchymal stem cells , 2012, Stem Cell Research & Therapy.

[9]  Jin Choul Chai,et al.  Genome-scale DNA methylation pattern profiling of human bone marrow mesenchymal stem cells in long-term culture , 2012, Experimental & Molecular Medicine.

[10]  Leping Li,et al.  Development of bone marrow mesenchymal stem cell culture in vitro. , 2012, Chinese medical journal.

[11]  M. Zenke,et al.  Monitoring of cellular senescence by DNA‐methylation at specific CpG sites , 2012, Aging cell.

[12]  F. Locatelli,et al.  Mesenchymal stromal cell therapy: a revolution in Regenerative Medicine? , 2012, Bone Marrow Transplantation.

[13]  W. Khan,et al.  Optimising Human Mesenchymal Stem Cell Numbers for Clinical Application: A Literature Review , 2012, Stem cells international.

[14]  Tomoaki Tanaka,et al.  Chromosomal variability of human mesenchymal stem cells cultured under hypoxic conditions , 2011, Journal of cellular and molecular medicine.

[15]  M. Esteller,et al.  DNA methylation in stem cell renewal and multipotency , 2011, Stem Cell Research & Therapy.

[16]  Wolfgang Wagner,et al.  Replicative senescence of mesenchymal stem cells causes DNA-methylation changes which correlate with repressive histone marks , 2011, Aging.

[17]  Huey-Kang Sytwu,et al.  Immunomodulatory properties of human adult and fetal multipotent mesenchymal stem cells , 2011, Journal of Biomedical Science.

[18]  T. He,et al.  Epigenetic Regulation of Mesenchymal Stem Cells: A Focus on Osteogenic and Adipogenic Differentiation , 2011, Stem cells international.

[19]  Yaojiong Wu,et al.  Epigenetic Dysregulation in Mesenchymal Stem Cell Aging and Spontaneous Differentiation , 2011, PLoS ONE.

[20]  M. Shi,et al.  Immunomodulatory properties and therapeutic application of mesenchymal stem cells , 2011, Clinical and experimental immunology.

[21]  Natalia de Isla,et al.  Long term culture of mesenchymal stem cells in hypoxia promotes a genetic program maintaining their undifferentiated and multipotent status , 2011, BMC Cell Biology.

[22]  C. Herberts,et al.  Risk factors in the development of stem cell therapy , 2011, Journal of Translational Medicine.

[23]  S. Welford,et al.  Hypoxia and Senescence: The Impact of Oxygenation on Tumor Suppression , 2011, Molecular Cancer Research.

[24]  A. Cometa,et al.  Ex vivo expansion of mesenchymal stromal cells. , 2011, Best practice & research. Clinical haematology.

[25]  Xiao-bing Fu,et al.  MSCs: Biological characteristics, clinical applications and their outstanding concerns , 2011, Ageing Research Reviews.

[26]  C. Chiu,et al.  Hypoxia inhibits senescence and maintains mesenchymal stem cell properties through down-regulation of E2A-p21 by HIF-TWIST. , 2011, Blood.

[27]  B. Tannous,et al.  miR-101 is down-regulated in glioblastoma resulting in EZH2-induced proliferation, migration, and angiogenesis , 2010, Oncotarget.

[28]  M. Esteller,et al.  Aberrant epigenetic landscape in cancer: how cellular identity goes awry. , 2010, Developmental cell.

[29]  P. Collas.  Programming differentiation potential in mesenchymal stem cells , 2010, Epigenetics.

[30]  J. Cigudosa,et al.  Retraction: Spontaneous human adult stem cell transformation. , 2010, Cancer research.

[31]  R. Bjerkvig,et al.  Spontaneous malignant transformation of human mesenchymal stem cells reflects cross-contamination: putting the research field on track - letter. , 2010, Cancer research.

[32]  Sterling Thomas,et al.  A survey of current software for network analysis in molecular biology , 2010, Human Genomics.

[33]  J. Cigudosa,et al.  Pitfalls in spontaneous in vitro transformation of human mesenchymal stem cells. , 2010, Experimental cell research.

[34]  Lee E. Edsall,et al.  Distinct epigenomic landscapes of pluripotent and lineage-committed human cells. , 2010, Cell stem cell.

[35]  Wolfgang Wagner,et al.  Different facets of aging in human mesenchymal stem cells. , 2010, Tissue engineering. Part B, Reviews.

[36]  Wolfgang Wagner,et al.  Age-dependent DNA methylation of genes that are suppressed in stem cells is a hallmark of cancer. , 2010, Genome research.

[37]  Carmen Koch,et al.  How to track cellular aging of mesenchymal stromal cells? , 2010, Aging.

[38]  D. Brash,et al.  Human Telomeres Are Hypersensitive to UV-Induced DNA Damage and Refractory to Repair , 2010, PLoS genetics.

[39]  Young-ho Kim.  Mesenchymal stem cells cultured under hypoxia escape from senescence via down-regulation of p16 and extracellular signal regulated kinase , 2010 .

[40]  Hélène Rouard,et al.  Clinical-grade production of human mesenchymal stromal cells: occurrence of aneuploidy without transformation. , 2010, Blood.

[41]  B. Korn,et al.  DNA methylation pattern changes upon long-term culture and aging of human mesenchymal stromal cells , 2010, Aging cell.

[42]  M. Miloso,et al.  Monitoring the genomic stability of in vitro cultured rat bone-marrow-derived mesenchymal stem cells , 2009, Chromosome Research.

[43]  T. de Lange.  How Telomeres Solve the End-Protection Problem , 2009, Science.

[44]  S. Gronthos,et al.  Mesenchymal Stem Cells Derived from Dental Tissues vs. Those from Other Sources: Their Biology and Role in Regenerative Medicine , 2009, Journal of dental research.

[45]  Jianhua Guo,et al.  Genome-Wide Analysis of Histone H3 Lysine9 Modifications in Human Mesenchymal Stem Cell Osteogenic Differentiation , 2009, PloS one.

[46]  A. Borkhardt,et al.  Epigenetic maintenance of stemness and malignancy in peripheral neuroectodermal tumors by EZH2 , 2009, Cell cycle.

[47]  P. Lønning,et al.  Long-term cultures of bone marrow-derived human mesenchymal stem cells frequently undergo spontaneous malignant transformation. , 2009, Cancer research.

[48]  Wolfgang Wagner,et al.  Aging and Replicative Senescence Have Related Effects on Human Stem and Progenitor Cells , 2009, PloS one.

[49]  E. Hara,et al.  Cellular senescence: Its role in tumor suppression and aging , 2009, Cancer science.

[50]  K. Friedman,et al.  Chromosome End Maintenance by Telomerase* , 2009, The Journal of Biological Chemistry.

[51]  Ren-Ke Li,et al.  A Transformed Cell Population Derived from Cultured Mesenchymal Stem Cells has no Functional Effect after Transplantation into the Injured Heart , 2009, Cell transplantation.

[52]  J. Blanco,et al.  Optimization of mesenchymal stem cell expansion procedures by cell separation and culture conditions modification. , 2008, Experimental hematology.

[53]  V. Moreno-Manzano,et al.  Hypoxia Causes Downregulation of Mismatch Repair System and Genomic Instability in Stem Cells , 2008, Stem cells.

[54]  D. Kaushal,et al.  Long-term in vitro expansion alters the biology of adult mesenchymal stem cells. , 2008, Cancer research.

[55]  V. Beneš,et al.  Replicative Senescence of Mesenchymal Stem Cells: A Continuous and Organized Process , 2008, PloS one.

[56]  S. Lehmann,et al.  Cell specific differences between human adipose-derived and mesenchymal-stromal cells despite similar differentiation potentials. , 2008, Experimental cell research.

[57]  P. Lansdorp.  Telomeres, stem cells, and hematology. , 2008, Blood.

[58]  A. Cometa,et al.  Human Bone Marrow-Derived Mesenchymal Stem Cells Do Not Undergo Transformation after Long-Term In Vitro Culture and Do Not Exhibit Telomere Maintenance Mechanisms. , 2007 .

[59]  D. S. Perez,et al.  Non-random inactivation of large common fragile site genes in different cancers , 2007, Cytogenetic and Genome Research.

[60]  Feng Zhao,et al.  Hypoxia enhances proliferation and tissue formation of human mesenchymal stem cells. , 2007, Biochemical and biophysical research communications.

[61]  Zhe Wang,et al.  Cytogenetic analysis of human bone marrow‐derived mesenchymal stem cells passaged in vitro , 2007, Cell biology international.

[62]  B. Spencer‐Dene,et al.  Murine but Not Human Mesenchymal Stem Cells Generate Osteosarcoma‐Like Lesions in the Lung , 2007, Stem cells.

[63]  P. Collas,et al.  Dynamics of adipogenic promoter DNA methylation during clonal culture of human adipose stem cells to senescence , 2007, BMC Cell Biology.

[64]  W. Reik.  Stability and flexibility of epigenetic gene regulation in mammalian development , 2007, Nature.

[65]  Kristian Helin,et al.  The Polycomb group proteins bind throughout the INK4A-ARF locus and are disassociated in senescent cells. , 2007, Genes & development.

[66]  R. Izadpanah,et al.  Biologic properties of mesenchymal stem cells derived from bone marrow and adipose tissue , 2006, Journal of cellular biochemistry.

[67]  G. Semenza,et al.  Spontaneous transformation of cultured mouse bone marrow-derived stromal cells. , 2006, Cancer research.

[68]  T. Glover,et al.  Common fragile sites as targets for chromosome rearrangements. , 2006, DNA repair.

[69]  Baojin Fu,et al.  Accumulated Chromosomal Instability in Murine Bone Marrow Mesenchymal Stem Cells Leads to Malignant Transformation , 2006, Stem cells.

[70]  Ardeshir Ghavamzadeh,et al.  BMC Cell Biology BioMed Central Research article Aging of mesenchymal stem cell in vitro , 2005 .

[71]  X. Chen,et al.  The Oct4 and Nanog transcription network regulates pluripotency in mouse embryonic stem cells , 2006, Nature Genetics.

[72]  Franca Fagioli,et al.  Expansion of mesenchymal stem cells isolated from pediatric and adult donor bone marrow , 2006, Journal of cellular biochemistry.

[73]  W. Ansorge,et al.  Comparative characteristics of mesenchymal stem cells from human bone marrow, adipose tissue, and umbilical cord blood. , 2005, Experimental hematology.

[74]  J. Cigudosa,et al.  Spontaneous human adult stem cell transformation. , 2005, Cancer research.

[75]  T. Ørntoft,et al.  DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis , 2005, Nature.

[76]  I. Bellantuono,et al.  Study of Telomere Length Reveals Rapid Aging of Human Marrow Stromal Cells following In Vitro Expansion , 2004, Stem cells.

[77]  U. Klingmüller,et al.  Effects of Telomerase Modulation in Human Hematopoietic Progenitor Cells , 2004, Stem cells.

[78]  Christian Clausen,et al.  Aging is associated with decreased maximal life span and accelerated senescence of bone marrow stromal cells. , 2003, Bone.

[79]  W. Hahn,et al.  Telomerase Maintains Telomere Structure in Normal Human Cells , 2003, Cell.

[80]  K. Mamchaoui,et al.  Telomerase can extend the proliferative capacity of human myoblasts, but does not lead to their immortalization. , 2003, Molecular cancer research : MCR.

[81]  C. Waller,et al.  Lack of telomerase activity in human mesenchymal stem cells , 2003, Leukemia.

[82]  T. Jensen,et al.  Telomerase expression extends the proliferative life-span and maintains the osteogenic potential of human bone marrow stromal cells , 2002, Nature Biotechnology.

[83]  C. Harley.  Telomerase is not an oncogene , 2002, Oncogene.

[84]  E. Blackburn.  Switching and Signaling at the Telomere , 2001, Cell.

[85]  M. Mastrogiacomo,et al.  Proliferation kinetics and differentiation potential of ex vivo expanded human bone marrow stromal cells: Implications for their use in cell therapy. , 2000, Experimental hematology.

[86]  D. Hanahan,et al.  The Hallmarks of Cancer , 2000, Cell.

[87]  R. G. Allen,et al.  Relationship between donor age and the replicative lifespan of human cells in culture: a reevaluation. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[88]  J. Shay,et al.  A survey of telomerase activity in human cancer. , 1997, European journal of cancer.

[89]  C Roskelley,et al.  A biomarker that identifies senescent human cells in culture and in aging skin in vivo. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[90]  Carol W. Greider,et al.  The telomere terminal transferase of tetrahymena is a ribonucleoprotein enzyme with two kinds of primer specificity , 1987, Cell.

[91]  L. Hayflick.  THE LIMITED IN VITRO LIFETIME OF HUMAN DIPLOID CELL STRAINS. , 1965, Experimental cell research.

[92]  P. Andrade,et al.  Ex vivo expansion of human mesenchymal stem cells on microcarriers. , 2011, Methods in molecular biology.

[93]  P. Collas,et al.  Chromatin states of core pluripotency-associated genes in pluripotent, multipotent and differentiated cells. , 2010, Biochemical and biophysical research communications.

[94]  D. Huso,et al.  Outgrowth of a transformed cell population derived from normal human BM mesenchymal stem cell culture. , 2005, Cytotherapy.